Herbert H. Engelhard, M.D., PhD.

University of Illinois at ChicagoChicago, Illinois - 60612 (312-355-0334) |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS2
- SINCE2009

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
June 2009 - October 2012
Glioblastoma
Temozolomide
Novottf-100a Device



